SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001387131-23-010769
Filing Date
2023-09-05
Accepted
2023-09-05 07:07:58
Documents
20
Period of Report
2023-09-05
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT tnxp-8k_090523.htm   iXBRL 8-K 43905
2 PRESS RELEASE ex99-01.htm EX-99.01 55638
6 GRAPHIC table_001.jpg GRAPHIC 71108
7 GRAPHIC table_002.jpg GRAPHIC 30896
8 GRAPHIC linechart_001.jpg GRAPHIC 71577
9 GRAPHIC linechart_002.jpg GRAPHIC 70671
10 GRAPHIC linechart_003.jpg GRAPHIC 52042
11 GRAPHIC linechart_004.jpg GRAPHIC 35812
12 GRAPHIC bar_001.jpg GRAPHIC 42056
  Complete submission text file 0001387131-23-010769.txt   1216526

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT tnxp-20230905.xsd EX-101.SCH 3024
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT tnxp-20230905_lab.xml EX-101.LAB 34240
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT tnxp-20230905_pre.xml EX-101.PRE 22365
14 EXTRACTED XBRL INSTANCE DOCUMENT tnxp-8k_090523_htm.xml XML 3191
Mailing Address 26 MAIN STREET, SUITE 101 CHATHAM NJ 07928
Business Address 26 MAIN STREET, SUITE 101 CHATHAM NJ 07928 212-980-9155
Tonix Pharmaceuticals Holding Corp. (Filer) CIK: 0001430306 (see all company filings)

IRS No.: 261434750 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36019 | Film No.: 231234120
SIC: 2834 Pharmaceutical Preparations